Silco Pharmaceuticals Limited Reports Earnings Results for the Third Quarter and Nine Months Ended March 31, 2023
For the nine months, sales was BDT 359.86 million compared to BDT 500.86 million a year ago. Net income was BDT 67.12 million compared to BDT 83.14 million a year ago. Basic earnings per share from continuing operations was BDT 0.65 compared to BDT 0.8 a year ago.